During the past decade, Atlanticare Regional Medical Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atlanticare Regional Medical Center" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Philadelphia College of Osteopathic Medicine" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Atlanticare Regional Medical Center" are "Covid19" (1 trials), "Heart Failure" (1 trials) and "Myofascial Pain Syndrome" (1 trials). Many other conditions were trialed in "Atlanticare Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Atlanticare Regional Medical Center" are "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban 2.5 MG" (1 trials), "OMT" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Atlanticare Regional Medical Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Atlanticare Regional Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Atlanticare Regional Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Atlanticare Regional Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".